These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24751900)

  • 1. Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses.
    Adam J; Wuillemin N; Watkins S; Jamin H; Eriksson KK; Villiger P; Fontana S; Pichler WJ; Yerly D
    PLoS One; 2014; 9(4):e95339. PubMed ID: 24751900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cells from HLA-B*57:01+ human subjects are activated with abacavir through two independent pathways and induce cell death by multiple mechanisms.
    Bell CC; Faulkner L; Martinsson K; Farrell J; Alfirevic A; Tugwood J; Pirmohamed M; Naisbitt DJ; Park BK
    Chem Res Toxicol; 2013 May; 26(5):759-66. PubMed ID: 23541086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.
    Illing PT; Vivian JP; Dudek NL; Kostenko L; Chen Z; Bharadwaj M; Miles JJ; Kjer-Nielsen L; Gras S; Williamson NA; Burrows SR; Purcell AW; Rossjohn J; McCluskey J
    Nature; 2012 Jun; 486(7404):554-8. PubMed ID: 22722860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of abacavir-specific effector and proliferating functions of CD8 T cells in abacavir-treated HIV-1 patients.
    Faridi RM; Patel S; Dharmani-Khan P; Gill J; Berka N; Khan FM
    Microbiol Immunol; 2020 Mar; 64(3):210-218. PubMed ID: 31876322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abacavir-reactive memory T cells are present in drug naïve individuals.
    Lucas A; Lucas M; Strhyn A; Keane NM; McKinnon E; Pavlos R; Moran EM; Meyer-Pannwitt V; Gaudieri S; D'Orsogna L; Kalams S; Ostrov DA; Buus S; Peters B; Mallal S; Phillips E
    PLoS One; 2015; 10(2):e0117160. PubMed ID: 25674793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B*57 : 01-restricted CD8+ T-cell activation.
    Naisbitt DJ; Yang EL; Alhaidari M; Berry NG; Lawrenson AS; Farrell J; Martin P; Strebel K; Owen A; Pye M; French NS; Clarke SE; O'Neill PM; Park BK
    AIDS; 2015 Nov; 29(18):2385-95. PubMed ID: 26372480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity.
    Norcross MA; Luo S; Lu L; Boyne MT; Gomarteli M; Rennels AD; Woodcock J; Margulies DH; McMurtrey C; Vernon S; Hildebrand WH; Buchli R
    AIDS; 2012 Jul; 26(11):F21-9. PubMed ID: 22617051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Elements Recognized by Abacavir-Induced T Cells.
    Yerly D; Pompeu YA; Schutte RJ; Eriksson KK; Strhyn A; Bracey AW; Buus S; Ostrov DA
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28686208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice.
    Song B; Aoki S; Liu C; Susukida T; Kuwahara S; Ito K
    Toxicology; 2021 Nov; 463():152971. PubMed ID: 34606953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced alloreactivity: A new paradigm for allorecognition.
    D'Orsogna LJ; Almeida CM; van Miert P; Zoet YM; Anholts JDH; Chopra A; Watson M; Witt C; John M; Claas FHJ
    Am J Transplant; 2019 Sep; 19(9):2606-2613. PubMed ID: 31125485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Animal Model of Abacavir-Induced HLA-Mediated Liver Injury.
    Song B; Aoki S; Liu C; Susukida T; Ito K
    Toxicol Sci; 2018 Apr; 162(2):713-723. PubMed ID: 29319822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA-B*57:01 binding and T-cell activation.
    Thomson PJ; Illing PT; Farrell J; Alhaidari M; Bell CC; Berry N; O'Neill PM; Purcell AW; Park KB; Naisbitt DJ
    Allergy; 2020 Mar; 75(3):636-647. PubMed ID: 31549414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire.
    Illing PT; van Hateren A; Darley R; Croft NP; Mifsud NA; King S; Kostenko L; Bharadwaj M; McCluskey J; Elliott T; Purcell AW
    Front Immunol; 2021; 12():672737. PubMed ID: 34093574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The avidity of cross-reactive virus-specific T cells for their viral and allogeneic epitopes is variable and depends on epitope expression.
    van den Heuvel H; Heutinck KM; van der Meer-Prins EMW; Franke-van Dijk MEI; van Miert PPMC; Zhang X; Ten Berge IJM; Claas FHJ
    Hum Immunol; 2018 Jan; 79(1):39-50. PubMed ID: 29100943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.
    Cardone M; Garcia K; Tilahun ME; Boyd LF; Gebreyohannes S; Yano M; Roderiquez G; Akue AD; Juengst L; Mattson E; Ananthula S; Natarajan K; Puig M; Margulies DH; Norcross MA
    J Clin Invest; 2018 Jul; 128(7):2819-2832. PubMed ID: 29782330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avidity determines T-cell reactivity in abacavir hypersensitivity.
    Adam J; Eriksson KK; Schnyder B; Fontana S; Pichler WJ; Yerly D
    Eur J Immunol; 2012 Jul; 42(7):1706-16. PubMed ID: 22585534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Conformational Dynamics in Abacavir-Induced Hypersensitivity Syndrome.
    Fodor J; Riley BT; Kass I; Buckle AM; Borg NA
    Sci Rep; 2019 Jul; 9(1):10523. PubMed ID: 31324847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01.
    Yun J; Marcaida MJ; Eriksson KK; Jamin H; Fontana S; Pichler WJ; Yerly D
    J Immunol; 2014 Apr; 192(7):2984-93. PubMed ID: 24591375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury.
    Monshi MM; Faulkner L; Gibson A; Jenkins RE; Farrell J; Earnshaw CJ; Alfirevic A; Cederbrant K; Daly AK; French N; Pirmohamed M; Park BK; Naisbitt DJ
    Hepatology; 2013 Feb; 57(2):727-39. PubMed ID: 22987284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.